| mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer S Rausch, C Schwentner, A Stenzl, J Bedke Human vaccines & immunotherapeutics 10 (11), 3146-3152, 2014 | 94 | 2014 |
| Survival prediction of clear cell renal cell carcinoma based on gene expression similarity to the proximal tubule of the nephron F Buettner, S Winter, S Rausch, A Reustle, S Kruck, K Junker, A Stenzl, ... European urology 68 (6), 1016-1020, 2015 | 68 | 2015 |
| Optical improvements in the diagnosis of bladder cancer: implications for clinical practice T Schubert, S Rausch, O Fahmy, G Gakis, A Stenzl Therapeutic advances in urology 9 (11), 251-260, 2017 | 61 | 2017 |
| Membranous NECTIN-4 expression frequently decreases during metastatic spread of urothelial carcinoma and is associated with enfortumab vedotin resistance N Klümper, DJ Ralser, J Ellinger, F Roghmann, J Albrecht, E Below, ... Clinical Cancer Research 29 (8), 1496-1505, 2023 | 56 | 2023 |
| Comprehensive metabolomic and lipidomic profiling of human kidney tissue: a platform comparison P Leuthold, E Schaeffeler, S Winter, F Büttner, U Hofmann, TE Mürdter, ... Journal of proteome research 16 (2), 933-944, 2017 | 56 | 2017 |
| Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure C Schwentner, A Sim, MD Balbay, T Todenhöfer, S Aufderklamm, ... World journal of surgical oncology 13, 1-6, 2015 | 54 | 2015 |
| Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size … S Rausch, T Heider, J Bedke, S Kruck, C Schwentner, K Fischer, A Stenzl, ... Urology 85 (1), 182-188, 2015 | 51 | 2015 |
| Characterization of the breast cancer resistance protein (BCRP/ABCG2) in clear cell renal cell carcinoma A Reustle, P Fisel, O Renner, F Büttner, S Winter, S Rausch, S Kruck, ... International journal of cancer 143 (12), 3181-3193, 2018 | 46 | 2018 |
| Squamous cell carcinogenesis and squamous cell carcinoma of the urinary bladder: a contemporary review with focus on nonbilharzial squamous cell carcinoma S Rausch, Y Lotan, RF Youssef Urologic Oncology: Seminars and Original Investigations 32 (1), 32. e11-32. e16, 2014 | 46 | 2014 |
| Fluorescence-guided bladder tumour resection: impact on survival after radical cystectomy G Gakis, T Ngamsri, S Rausch, J Mischinger, T Todenhöfer, ... World journal of urology 33, 1429-1437, 2015 | 43 | 2015 |
| Metabolic and lipidomic reprogramming in renal cell carcinoma subtypes reflects regions of tumor origin E Schaeffeler, F Büttner, A Reustle, V Klumpp, S Winter, S Rausch, P Fisel, ... European urology focus 5 (4), 608-618, 2019 | 42 | 2019 |
| Impaired estimated glomerular filtration rate is a significant predictor for non–muscle-invasive bladder cancer recurrence and progression—Introducing a novel prognostic model … S Rausch, J Hennenlotter, T Todenhöfer, S Aufderklamm, C Schwentner, ... Urologic Oncology: Seminars and Original Investigations 32 (8), 1178-1183, 2014 | 41 | 2014 |
| Integrative-omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy A Reustle, M Di Marco, C Meyerhoff, A Nelde, JS Walz, S Winter, ... Genome medicine 12, 1-24, 2020 | 38 | 2020 |
| Transurethral resection of bladder tumors: next-generation virtual reality training for surgeons E Neumann, J Mayer, GI Russo, B Amend, S Rausch, S Deininger, ... European Urology Focus 5 (5), 906-911, 2019 | 38 | 2019 |
| Targeted vs systematic robot‐assisted transperineal magnetic resonance imaging‐transrectal ultrasonography fusion prostate biopsy J Mischinger, S Kaufmann, GI Russo, N Harland, S Rausch, B Amend, ... BJU international 121 (5), 791-798, 2018 | 38 | 2018 |
| Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice J Bedke, J Heide, S Ribback, S Rausch, M de Martino, M Scharpf, A Haitel, ... Bju International 121 (1), 84-92, 2018 | 37 | 2018 |
| Nonbilharzial squamous cell carcinoma and transitional cell carcinoma with squamous differentiation of the lower and upper urinary tract S Rausch, R Hofmann, R von Knobloch Urology annals 4 (1), 14-18, 2012 | 37 | 2012 |
| Methylomes of renal cell lines and tumors or metastases differ significantly with impact on pharmacogenes S Winter, P Fisel, F Büttner, S Rausch, D D’Amico, J Hennenlotter, ... Scientific reports 6 (1), 29930, 2016 | 34 | 2016 |
| Robot–assisted radical cystectomy and intracorporeal urinary diversion–safe and reproducible? A Sim, MD Balbay, T Todenhöfer, S Aufderklamm, O Halalsheh, ... Central European Journal of Urology 68 (1), 18, 2015 | 34 | 2015 |
| Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancer T Todenhöfer, J Hennenlotter, P Guttenberg, S Mohrhardt, U Kuehs, ... BMC cancer 15, 1-11, 2015 | 32 | 2015 |
